Showing results (31-40 of 285) with videos related to
Sort By:
Pageof 29
Liver International : Official Journal of the International Association for the Study of the Liver|February 11, 2018
Treatment of hepatitis C virus infection with direct-acting antiviral agents: 100% cure?Tarik Asselah, Patrick Marcellin, Raymond F SchinaziAntiviral Therapy|October 9, 2008
Dynamic evolution of therapy for chronic hepatitis C: how will novel agents be incorporated into the standard of care?Stefan Zeuzem, David R Nelson, Patrick MarcellinJournal of Hepatology|August 19, 2007
Which patients with genotype 1 chronic hepatitis C can benefit from prolonged treatment with the 'accordion' regimen?Patrick Marcellin, E Jenny Heathcote, Antonio CraxìClinics in Liver Disease|August 3, 2013
HBsAg quantification to predict natural history and treatment outcome in chronic hepatitis B patientsMichelle Martinot-Peignoux, Tarik Asselah, Patrick MarcellinLiver International : Official Journal of the International Association for the Study of the Liver|December 23, 2014
HBsAg quantification to optimize treatment monitoring in chronic hepatitis B patientsMichelle Martinot-Peignoux, Tarik Asselah, Patrick MarcellinExpert Opinion on Investigational Drugs|November 18, 2008
Clevudine: a promising therapy for the treatment of chronic hepatitis BTarik Asselah, Olivier Lada, Rami Moucari, et al.Liver International : Official Journal of the International Association for the Study of the Liver|December 31, 2013
HCV direct-acting antiviral agents: the best interferon-free combinationsRaymond Schinazi, Philippe Halfon, Patrick Marcellin, et al.Journal of Hepatology|June 5, 2012
Genomics and HCV infection: progression of fibrosis and treatment responseEmilie Estrabaud, Michel Vidaud, Patrick Marcellin, et al.Liver International : Official Journal of the International Association for the Study of the Liver|December 31, 2013
HBsAg quantification: useful for monitoring natural history and treatment outcomeMichelle Martinot-Peignoux, Martine Lapalus, Tarik Asselah, et al.Journal of Clinical Gastroenterology|June 25, 2002
Treatment of hepatitis C virus genotype 4-related cirrhosis: ribavirin and interferon combination compared with interferon aloneAbraham Koshy, John P Madda, Patrick Marcellin, et al.Pageof 29